A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
A phase 2 trial of SAR445877 in gastric & gastro-oesophageal junction cancer and oesophageal cancer, run by Sanofi, now recruiting.
Overview
A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer is a phase 2 interventional study registered as NCT07692204 by Sanofi, with 30 participants planned, started 2026-07-01 and due to reach its primary completion in 2028-08-02. Interventions recorded: SAR445877.
Similar pages
not linked directly; found by shared links- TrialUsing 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- Trial64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialA First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialSL-28 for Advanced Solid Tumours
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialA Study of MT-4561 in Patients With Various Advanced Solid Tumors
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialStudy to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
Shares Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialTherapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer
Shares Gastric & gastro-oesophageal junction cancer and the tag pipeline.
- TrialA Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
Shares Gastric & gastro-oesophageal junction cancer and the tag pipeline.